Qbic has participated in a $32.8m funding round for EyeD, consisting of $9.4m in equity and another $23.4m in debt financing and government grants.
EyeD, a Belgium-based developer of an implant to treat glaucoma that was spun out of the University Hospital of Liège (CHU Liège), has raised a total of €28m ($32.8m) from investors including multi-university venture fund Qbic.
Qbic participated in an $9.4m equity tranche together with Fund+ and assorted private investors. The remaining $23.4m came in the form of bank loans and grant financing from the Walloon government, though further details were not disclosed.
Founded in 2012, EyeD has…
Thierry Heles
Thierry Heles is editor-at-large of Global University Venturing and Global Corporate Venturing, and host of the Beyond the Breakthrough podcast.
